Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
285
-
Total 13F shares, excl. options
-
89.2M
-
Shares change
-
-3.46M
-
Total reported value, excl. options
-
$2.9B
-
Value change
-
-$102M
-
Put/Call ratio
-
0.93
-
Number of buys
-
136
-
Number of sells
-
-147
-
Price
-
$32.49
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q2 2024
340 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q2 2024.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 285 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89.2M shares
of 106M outstanding shares and own 84.29% of the company stock.
Largest 10 shareholders include BlackRock Inc. (16.5M shares), VANGUARD GROUP INC (9.55M shares), INGALLS & SNYDER LLC (8.24M shares), RENAISSANCE TECHNOLOGIES LLC (6.91M shares), Parallel Advisors, LLC (3.82M shares), STATE STREET CORP (3.5M shares), DIMENSIONAL FUND ADVISORS LP (2.68M shares), Novo Holdings A/S (2.41M shares), GEODE CAPITAL MANAGEMENT, LLC (2.28M shares), and Boston Trust Walden Corp (1.58M shares).
This table shows the top 285 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.